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Abstract MUFAs are unsaturated FAs with one double bond 
and are derived from endogenous synthesis and dietary in-
take. Accumulating evidence has suggested that plasma and 
erythrocyte MUFA levels are associated with cardiometa-
bolic disorders, including CVD, T2D, and metabolic syn-
drome (MS). Previous genome-wide association studies 
(GWASs) have identified seven loci for plasma and erythro-
cyte palmitoleic and oleic acid levels in populations of Euro-
pean origin. To identify additional MUFA-associated loci and 
the potential functional variant at each locus, we performed 
ethnic-specific GWAS meta-analyses and trans-ethnic meta-
analyses in more than 15,000 participants of Chinese and 
European ancestry. We identified novel genome-wide signifi-
cant associations for vaccenic acid at FADS1/2 and PKD2L1 
[log10(Bayes factor)  8.07] and for gondoic acid at FADS1/2 
and GCKR [log10(Bayes factor)  6.22], and also observed 
improved fine-mapping resolutions at FADS1/2 and GCKR 
loci. The greatest improvement was observed at GCKR, 
where the number of variants in the 99% credible set was 
reduced from 16 (covering 94.8 kb) to 5 (covering 19.6 kb, 
including a missense variant rs1260326) after trans-ethnic 
meta-analysis. We also confirmed the previously reported as-
sociations of PKD2L1, FADS1/2, GCKR, and HIF1AN with 
palmitoleic acid and of FADS1/2 and LPCAT3 with oleic acid 
in the Chinese-specific GWAS and the trans-ethnic meta-anal-
yses. Pathway-based analyses suggested that the identified 
loci were in unsaturated FA metabolism and signaling path-
ways.  Our findings provide novel insight into the genetic 
basis relevant to MUFA metabolism and biology.—Hu, Y., T. 
Tanaka, J. Zhu, W. Guan, J. H. Y. Wu, B. M. Psaty, B. McK-
night, I. B. King, Q. Sun, M. Richard, A. Manichaikul, A. C. 
Frazier-Wood, E. K. Kabagambe, P. N. Hopkins, J. M. Ordo-
vas, L. Ferrucci, S. Bandinelli, D. K. Arnett, Y.-D. I. Chen, S. 
Liang, D. S. Siscovick, M. Y. Tsai, S. S. Rich, M. Fornage, F. B. 
Hu, E. B. Rimm, M. K. Jensen, R. N. Lemaitre, D. Mozaffar-
ian, L. M. Steffen, A. P. Morris, H. Li, and X. Lin. Discovery 
and fine-mapping of loci associated with MUFAs through 
trans-ethnic meta-analysis in Chinese and European popula-
tions. J. Lipid Res. 2017. 58: 974–981.
Supplementary key words  genetics  •  fatty  acid/desaturases  •  fatty 
acid/metabolism • fatty acid/biosynthesis • monounsaturated fatty acid
MUFAs are nonessential unsaturated FAs with one dou-
ble bond in the carbon chain, mainly including palmitoleic 
acid (16:1n-7), vaccenic acid (18:1n-7), oleic acid (18:1n-
9), gondoic acid (20:1n-9), erucic acid (22:1n-9), and ner-
vonic acid (24:1n-9). Oleic acid, the most abundant MUFA 
in lipids (1), is the predominant dietary MUFA (rich in 
plant oils, such as olive, canola, hazelnut, almond, and 
rapeseed, and in animal-derived fats, such as lard, tallow, 
and butter) (1, 2). Oleic and palmitoleic acid can be syn-
thesized through de novo lipogenesis (DNL) by -9 desatu-
ration of stearic and palmitic acid, respectively, in liver and 
adipose tissue (3, 4). Vaccenic, gondoic, erucic, and ner-
vonic acids are elongation products of palmitoleic or oleic 
acid through endogenous synthesis (1).
MUFAs are important components of cell membranes and 
serve as energy sources through -oxidation in the mitochon-
dria (for example, in the skeletal muscle during exercise) 
(5). Previous animal studies and clinical trials have suggested 
that palmitoleic and oleic acid play a role in lipid and glucose 
regulation (6–9). In addition, epidemiological studies indi-
cated that elevated levels of specific plasma and erythrocyte 
membrane MUFA levels (palmitoleic, vaccenic, erucic, and 
nervonic acids) were associated with increased risk of T2D 
(10), metabolic abnormalities (11), and CVD (12–14) in Eu-
ropean populations, and studies in Chinese Hans also ob-
served that higher levels of erythrocyte palmitoleic and oleic 
acid levels were associated with increased risk of metabolic 
syndrome (MS) and T2D (15, 16). Therefore, these MUFAs 
are of great importance to cardiometabolic diseases.
Recently, genome-wide association studies (GWASs) 
have identified seven loci (FADS1/2, PKD2L1, HIF1AN, 
GCKR, 2p13, LPCAT3, and TRIM58) associated with plasma 
and erythrocyte palmitoleic acid and/or oleic acid levels in 
populations of European ancestry (17, 18). However, these 
loci have not been replicated in other ethnic groups with 
different genetic architecture and dietary intake (19). 
More importantly, the potential functional variants at these 
loci and the genetic variants that affect circulating levels 
of vaccenic, gondoic, erucic, and nervonic acid remain 
unknown. Therefore, we first performed ethnic-specific 
GWAS meta-analyses in populations consisting of 3,521 
Chinese individuals from two cohorts and of 12,020 Euro-
pean individuals from eight cohorts, respectively, and then 
combined the GWAS data from these two ethnic groups 
by trans-ethnic meta-analysis. We further conducted trans-
ethnic fine-mapping of the identified loci by construction 
of 99% credible sets.
Abbreviations: ARIC, Atherosclerosis Risk in Communities; BF, 
Bayes factor; CARDIA, Coronary Artery Risk Development in Young 
Adults; CHARGE, Cohorts for Heart and Aging Research in Genomic 
Epidemiology; CHS, Cardiovascular Health Study; cis-eQTL, cis-expres-
sion quantitative trait loci; DNL, de novo lipogenesis; GATES, gene-
based association test using extended Simes procedure; GCKR, 
glucokinase regulator; GOLDN, Genetics of Lipid Lowering Drugs and 
Diet Network; GTEx, Genotype-Tissue Expression database; GWAS, ge-
nome-wide association study; HPFS, Health Professionals Follow-Up 
Study; InCHIANTI, Invecchiare in Chianti Study; LD, linkage disequi-
librium; MANTRA, meta-analysis of trans-ethnic association studies; 
MESA, Multi-Ethnic Study of Atherosclerosis; MS, metabolic syndrome; 
NHAPC, Nutrition and Health of Aging Population in China; NHS, 
Nurses’ Health Study; Phet, posterior probability of heterogeneity; SPU, 
sum of powered score.
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Chinese-specific GWAS meta-analysis included data on 3,521 
Chinese-ancestry participants from two cohorts: the Nutrition and 
Health of Aging Population in China (NHAPC) (20) and the 
Multi-Ethnic Study of Atherosclerosis (MESA) (21). European-
specific GWAS meta-analysis included data on 12,020 European-
ancestry participants from eight cohorts: the Atherosclerosis Risk 
in Communities study (ARIC) (22), the Coronary Artery Risk De-
velopment in Young Adults study (CARDIA) (23), the Cardiovas-
cular Health Study (CHS) (24), the Genetics of Lipid Lowering 
Drugs and Diet Network (GOLDN) (25), the Nurses’ Health 
Study (NHS) (26), the Health Professionals Follow-Up Study 
(HPFS) (27), the Invecchiare in Chianti Study (InCHIANTI) 
(28), and MESA. Summary statistics of the two ethnic-specific 
GWAS meta-analyses were combined in the trans-ethnic meta-
analysis. Written informed consent was obtained from all partici-
pants, and each study was approved by local ethics committees. 
Detailed descriptions of each cohort are provided in the supple-
mental Methods.
FA measurements
For ARIC, CARDIA, CHS, and MESA, fasting plasma phospho-
lipids were isolated by TLC, and FAs were subsequently quantified 
by gas chromatography. For InCHIANTI, fasting FAs were mea-
sured in total plasma by gas chromatography. For GOLDN, NHS, 
HPFS, and NHAPC, fasting erythrocyte FAs were measured by gas 
chromatography or gas-liquid chromatography. FAs were identi-
fied for each study, and concentration of each FA was expressed 
as percentage of total FAs. Detailed methods of MUFA measure-
ment in each cohort are provided in supplemental Methods. 
Ethnic-specific GWAS meta-analyses were performed for associa-
tions with palmitoleic, vaccenic, oleic, gondoic, erucic, and ner-
vonic acids in Chinese populations, and for associations with 
vaccenic, gondoic, erucic, and nervonic acids in European popu-
lations (Table 1).
Genotyping and quality control
Illumina 370, 550, and 660W genotyping arrays were used on 
DNA samples from CHS, InCHIANTI, and NHAPC, respectively, 
while Affymetrix 6.0 genotyping arrays were used in ARIC, CAR-
DIA, GOLDN, NHS, HPFS, and MESA. SNPs with call rate <95% 
(ARIC, CARDIA, MESA, NHS, and HPFS) or <97% (CHS, 
GOLDN, InCHIANTI, and NHAPC) were excluded. SNPs with 
significant departure from Hardy-Weinberg equilibrium expecta-
tions at P < 104 (for NHS and HPFS), P < 105 (for ARIC and 
CHS), or P < 106 (for CARDIA, GOLDN, InCHIANTI, MESA, 
and NHAPC) were excluded. SNPs with minor allele frequency 
<1% were also excluded from these analyses. The software used 
for imputation included MACH (29) (ARIC, GOLDN, NHS, 
HPFS, and InCHIANTI), BEAGLE (30) (CARDIA), BIMBAM 
(31) (CHS), and IMPUTE (32) (MESA and NHAPC). SNPs with 
imputation information measure <0.5 or imputation quality score 
(estimated r2) <0.3 were excluded (33). Methods of genotyping, 
imputation, and quality control for each cohort are explained in 
detail in supplemental Methods.
Chinese- and European-specific GWAS meta-analyses
For each individual FA, GWAS analysis of approximately 2.2 
million genotyped and imputed SNPs was performed separately 
in each cohort. Linear regression models were applied to test as-
sociations between SNPs and individual FA levels under an addi-
tive genetic model. All analyses were adjusted for age, sex, site of 
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for population admixture. Genomic control corrections were applied 
to each study before meta-analysis to further minimize potential 
confounding by population stratification (34). Cohort-specific as-
sociation results were then combined by using inverse-variance 
based meta-analysis in METAL software (http://www.sph.umich.
edu/csg/abecasis/metal). In Chinese- and European-specific 
meta-analyses, SNPs that were present in only one study were ex-
cluded. The linkage disequilibrium (LD) measures (r2) were cal-
culated by using the HapMap Phase II data (http://archive.
broadinstitute.org/mpg/snap/ldsearchpw.php).
Trans-ethnic meta-analysis
Trans-ethnic meta-analysis was performed to identify addi-
tional novel loci for MUFA levels, to narrow the functional re-
gions represented by the identified association signals, and also to 
test the heterogeneity of the identified loci across ethnic groups. 
Association statistics in the Chinese and European populations 
were combined by using Meta-ANalysis of Trans-ethnic Associa-
tion studies (MANTRA; using a Bayesian framework) (35). MAN-
TRA allows for heterogeneity among distinct ethnic populations 
and has increased power and mapping resolution compared with 
fixed- and random-effects meta-analysis (35). A log10[Bayes factor 
(BF)] 6 is considered as significant evidence of an association, 
and SNPs with posterior probability of heterogeneity (Phet) >0.5 
were interpreted as having significant heterogeneity. Trans-ethnic 
meta-analysis using the fixed-effect model by METAL software was 
also performed. The 95% and 99% credible sets surrounding the 
most significant SNP at each locus based on the European-ances-
try GWAS meta-analysis and the trans-ethnic meta-analysis of Eu-
ropean and Chinese populations were calculated, respectively. 
The 95% and 99% credible sets at each locus was established by 1) 
defining a ±500 kb region surrounding the most significant SNP; 
2) ranking the regional SNPs within this region according to their 
BF values; and 3) adding SNPs until the cumulative posterior 
probabilities of the ranked SNPs achieved the 95% and 99% con-
fidence. Variants in the 99% credible sets were examined for se-
quence overlap with potential regulatory sites (promoter histone 
marks, enhancer histone marks, and DNase hypersensitivity) by 
searching the HaploReg V4.1 database (36). The location of each 
SNP in the fine-mapping section was extracted from the 1000 Ge-
nomes Brower (https://www.ncbi.nlm.nih.gov/variation/tools/ 
1000genomes/).
cis-Expression quantitative trait loci analysis
In the cis-expression quantitative trait loci (cis-eQTL) analysis, 
we examined the associations of significant SNPs (Table 2) with 
RNA levels of nearby genes in the public Genotype-Tissue Expres-
sion database (GTEx; http://gtexportal.org/home/). Adipose 
tissue, skeletal muscle, and liver were considered as the most im-
portant tissues in FA metabolism (4), and these three tissues were 
selected in the GTEx browser.
Gene- and pathway-based analysis
For the gene-based analysis, sum of powered score (SPUs) (37) 
and gene-based association test using extended Simes procedure 
(GATES) (38) were used, which integrated GWAS summary statis-
tics based on SNP positions and LD information. SNPs were as-
signed to specific genes by PLINK (http://zzz.bwh.harvard.edu/
plink/). For the pathway-based analysis, aSPUpath (37) and GATES-
Simes (39) were used. These methods were implemented in the 
public R package aSPU (https://cran.r-project.org/web/packages/
aSPU/). In total, 4,405 and 4,502 genes mapped to 186 Kyoto Ency-
clopedia of Genes and Genomes pathways were analyzed in Chinese 
and European populations, respectively. The significant threshold 
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and 0.05/(4502 × 6) = 1.85 × 106 in Chinese and European popula-
tions, respectively, for the gene-based analysis, and 0.05/(186 × 6) = 
4.48 × 105 for the pathway-based analysis.
Associations of the identified loci with cardiometabolic 
outcomes
The publicly available GWAS results from CARDIoGRAM-
plusC4D (http://www.cardiogramplusc4d.org/), DIAGRAM 
(http://diagram-consortium.org/index.html), and GIANT (http:// 
www.broadinstitute.org/collaboration/giant/index.php/) con-
sortia were used to explore the associations of the significant loci 
(Table 2) identified in our study with coronary artery disease 
(CAD), T2D, and BMI. SNPs with P < 0.05 were considered to be 




The study sample included 3,521 individuals of Chinese 
origin from the NHAPC and MESA cohorts and 12,020 in-
dividuals of European origin from cohorts including ARIC, 
CARDIA, CHS, GOLDN, NHS, HPFS, InCHIANTI, and 
MESA (Table 1). Participants comprised mostly middle-
aged to older individuals (mean age across the cohorts 
ranged from 45.8 to 75.0 years), and approximately 50% of 
them were male, except for the NHS (female only) and 
HPFS (male only) cohorts. FA levels were all expressed as 
the percentage of total FAs (Table 1).
Novel genetic associations
Three loci (PKD2L1, FADS1/2, and GCKR) showed novel 
genome-wide significant associations with vaccenic acid 
and/or gondoic acid in the meta-analysis. Minor allele A of 
PKD2L1-rs603424 was significantly associated with lower 
vaccenic acid level in the European-specific GWAS meta-
analysis (P = 5.75 × 1017; Table 2, supplemental Table S1, 
and supplemental Figs. S1 and S2) and in the trans-ethnic 
meta-analysis (BF = 14.8, P = 1.65 × 1016; Table 2). Minor 
alleles of FADS1/2 variants were associated with higher vac-
cenic and gondoic acid levels in the European-specific 
GWAS meta-analysis (P  9.90 × 109; Table 2, supplemen-
tal Table S1, and supplemental Figs. S1 and S2) and in the 
trans-ethnic meta-analysis (BF  8.07, P  7.22 × 1010; 
Table 2), and were also confirmed in the Chinese-specific 
GWAS meta-analysis (P  3.67 × 103; Table 2). Minor al-
lele T of GCKR-rs780094 was associated with a lower gon-
doic acid level in the trans-ethnic meta-analysis (BF = 6.22, 
P = 2.95 × 108; Table 2) and showed suggestive signifi-
cance in the European-specific GWAS meta-analysis (P = 
6.31 × 107; Table 2). These novel associations exhibited 
no evidence of heterogeneity between Chinese and Euro-
pean populations, with consistent association directions 
and comparable effect sizes (Phet  0.090; Table 2).
Previously reported genetic associations
Reported associations of PKD2L1, FADS1/2, GCKR, and 
HIF1AN with palmitoleic acid in European populations 
(18) were confirmed in the Chinese-specific GWAS meta-
analysis (P  6.57 × 103; Table 2) and in the trans-ethnic 
meta-analysis (BF  8.84, P  7.90 × 1011; Table 2). Re-
ported association of FADS1/2 with oleic acid in European 
populations (17, 18) reached genome-wide significance in 
the Chinese-specific GWAS meta-analysis (P = 2.92 × 1010; 
Table 2) and in the trans-ethnic meta-analysis (BF = 38.0, 
P = 1.44 × 1039; Table 2). These loci exhibited no evidence 
of heterogeneity between Chinese and European popula-
tions (Phet  0.061; Table 2). Association of LPCAT3 with 
oleic acid, previously reported in the Framingham Heart 
Offspring Study (17), reached genome-wide significance in 
the Chinese-specific GWAS meta-analysis (P = 1.86 × 108; 
Table 2) and in the trans-ethnic meta-analysis using MAN-
TRA (BF = 6.12; Table 2), but it was not replicated in the 
European populations from the Cohorts for Heart and Ag-
ing Research in Genomic Epidemiology (CHARGE) Con-
sortium (18) (P = 0.451; Table 2) or in the trans-ethnic 
meta-analysis using METAL (P = 0.282; Table 2). This locus 
showed significant heterogeneity between Chinese and Eu-
ropean populations (Phet = 1; Table 2). In addition, we 
failed to replicate the previously reported associations of 
2p13 with palmitoleic acid (18) in Chinese populations 
(P = 0.992; supplemental Table S2), and of TRIM58 with 
oleic acid (17) in the trans-ethnic meta-analysis (BF = 0.005; 
supplemental Table S2).
Fine mapping
Although the SNPs showing the strongest association are 
not necessarily the functional variants, owing to factors 
such as sampling variation and LD patterns, it is still rea-
sonable to think that functional variants are among the 
SNPs interrogated in these loci. By comparing the 99% 
credible sets calculated on the basis of the European- 
ancestry meta-analysis and on the basis of the trans-ethnic 
meta-analysis, we observed improvements in fine-mapping 
resolution at FADS1/2 and GCKR loci.
The number of SNPs in the 99% credible set at FADS1/2 
locus was reduced from 16 (covering 54.1 kb) to 14 (cover-
ing 53.5 kb, from rs174535 located 32.3 kb upstream of 
FADS2 to rs174577 in the first intron of FADS2), 24 (cover-
ing 79.6 kb) to 23 (covering 62.0 kb, from rs174528 located 
40.2 kb upstream of FADS2 to rs174578 in the second in-
tron of FADS2), and 15 (covering 54.1 kb) to 12 (covering 
53.5 kb, from rs174535 located 32.3 kb upstream of FADS2 
to rs174577 in the first intron of FADS2), for association 
with palmitoleic, vaccenic, and oleic acid, respectively (sup-
plemental Tables S3–S5), and these SNPs show strong LD 
with each other (r2  0.590 in CEU and r2  0.927 in 
CHB+JPT). After trans-ethnic meta-analysis, the 12 highly 
correlated SNPs, including rs174535, rs174545, rs174546, 
rs102275, rs174536, rs174537, rs174550, rs174547, 
rs174574, rs174576, rs174577, and rs1535 (r2 = 1 in CEU 
and r2  0.927 in CHB+JPT, from rs174535 located 32.3 kb 
upstream of FADS2 to rs174577 in the first intron of FADS2) 
in the 99% credible set of oleic acid were shared across the 
associations with palmitoleic, vaccenic, and oleic acid (sup-
plemental Table S3). We further performed a Fisher’s ex-
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analysis-based 99% credible sets were enriched for poten-
tial regulatory sites (promoter histone marks, enhancer 
histone marks, and DNase hypersensitivity) when com-
pared with the SNPs in the European-ancestry GWAS-based 
99% credible sets. However, no significant enrichment was 
observed after trans-ethnic meta-analysis (P  0.533). 
These findings suggested that the improved fine-mapping 
resolution at FADS1/2 locus is likely resulted from the in-
creased sample size after trans-ethnic meta-analysis.
The greatest improvement in fine-mapping resolution 
was observed at the GCKR locus, where the number of SNPs 
in the 99% credible set was reduced from 16 (covering 94.8 
kb) on the basis of the European-ancestry meta-analysis to 
five (covering 19.6 kb, from rs1260326 located in the 15th 
exon of GCKR to rs2911711 located 4.0 kb downstream of 
GCKR) after trans-ethnic meta-analysis. The five SNPs in 
the 99% credible, in strong LD with each other (r2  0.805 
in CEU and r2  0.827 in CHB+JPT), included one mis-
sense SNP (rs1260326, p.P446L, located in the 15th exon 
of GCKR), two intronic SNPs (rs780094 and rs780093 lo-
cated in the 16th and 17th intron of GCKR, respectively), 
and two SNPs in the downstream of GCKR (rs1260333 and 
rs2911711 located 2.1 and 4.0 kb downstream of GCKR, re-
spectively) (supplemental Tables S4 and S5).
The 99% credible sets based on the European-ancestry 
and trans-ethnic meta-analyses at PKD2L1 locus contained 
only one SNP (rs603424). Therefore, the posterior proba-
bility that rs603424 was functional (or tagged an unobserved 
functional variant) was greater than 99% for PKD2L1. 
PKD2L1-rs603424 is located in the second intron of the 
PKD2L1 gene and overlapped with an enhancer histone 
mark (H3K4me1, H3K27ac and H3K9ac) in the adipose 
tissue when we searched the Roadmap Epigenomics data-
base (40) using HaploReg V4.1 (supplemental Tables S4 
and S5). The previously reported signal HIF1AN-rs10883511 
for association with palmitoleic acid (18) is located 224 kb 
away from PKD2L1-rs603424, and these two SNPs are 
independent from each other (r2 = 0.013 in CEU and 
r2 = 0.001 in CHB+JPT). Because PKD2L1-rs603424 was 
the strongest association signal ( = 0.032, P = 5.32 × 
1014) in the ±500 kb genomic region of HIF1AN-
rs10883511 ( = 0.023, P = 6.44 × 108), we could not con-
struct credible sets or perform trans-ethnic fine-mapping at 
HIF1AN locus.
cis-eQTL analysis
To gain more insight into the potential functional roles 
of the genome-wide significant loci (Table 2), we per-
formed cis-eQTL analysis by searching the publicly avail-
able GTEx database in adipose tissue, skeletal muscle, and 
liver. Results suggested that the minor allele A of PKD2L1-
rs603424 was significantly associated with decreased RNA 
level of SCD (stearoyl-CoA desaturase; encodes the -9 desatu-
rase in the DNL pathway) in the adipose tissue (P  3.94 × 
106; supplemental Table S6). These results further strength-
ened our findings from the GWAS meta-analyses that the 
minor allele A of PKD2L1-rs603424 was significantly associ-
ated with decreased levels of palmitoleic and vaccenic acids 
(P  5.32 × 1014; Table 2).
Gene- and pathway-based analysis
Gene-based analysis improves the statistical power by 
combining all SNPs in a gene into a gene-based score, 
which reduces the burden of multiple testing and incorpo-
rates multiple independent association signals (41). To 
identify additional genes and pathways that contribute to 
circulating MUFA levels and gain insight into the underly-
ing mechanisms, we performed gene- and pathway-based 
association testing using GWAS summary statistics in Chi-
nese and European populations, respectively. Four genes 
(FEN1, FADS1, FADS2, and LPCAT3; 27 SNPs) for associa-
tion with oleic acid in the Chinese populations and six 
genes (SCD, WNT8B, NDUFB8, FEN1, FADS1, and FADS2; 64 
SNPs) for association with palmitoleic, vaccenic, oleic, 
and/or gondoic acid in the European populations reached 
gene-based significance (P  1.60 × 106; supplemental 
Table S7) using both SPU and GATES methods. Because 
the association signals at WNT8B and NDUFB8 genes for 
association with palmitoleic acid in the European popula-
tions are in strong LD with the reported SNP HIF1AN-
rs10883511 (18) (r2  0.832), we did not consider them as 
novel loci. Pathways, including biosynthesis of unsaturated 
FAs, -linolenic acid metabolism, glycerophospholipid me-
tabolism, and PPAR signaling pathway, were significantly 
associated with palmitoleic, vaccenic, oleic, and/or gon-
doic acid levels in the pathway-based analyses (P  2.28 × 
105; supplemental Table S8).
Associations of the identified loci with cardiometabolic 
outcomes
Finally, we searched the public GWAS databases of CAR-
DIoGRAMplusC4D, DIAGRAM, and GIANT Consortia to 
examine whether the significant loci (Table 2) were associ-
ated with cardiometabolic outcomes. We found significant 
association of FADS1/2-rs102275 with T2D (P = 0.002; sup-
plemental Table S9) and of GCKR-rs780094 with BMI (P = 
6.98 × 105; supplemental Table S10). Suggestive evidence 
was also observed for associations with CAD (PKD2L1-
rs603424; P = 0.024; supplemental Table S11) and T2D 
(GCKR-rs780094; P = 0.025; supplemental Table S9).
DISCUSSION
In this first trans-ethnic meta-analysis of MUFA levels in 
Chinese and European populations, we identified novel as-
sociations of FADS1/2, PKD2L1, and GCKR with vaccenic 
and/or gondoic acid and replicated the previously re-
ported associations with palmitoleic and/or oleic acid for 
loci at FADS1/2, PKD2L1, GCKR, HIF1AN, and LPCAT3 in 
the Chinese-specific GWAS and the trans-ethnic meta-anal-
yses. We also observed substantial improvement in the fine-
mapping resolution at the GCKR locus after trans-ethnic 
meta-analysis.
The -9 desaturase, encoded by SCD, plays an important 
role in MUFA metabolism (42). It catalyzes the desatura-
tion reaction from palmitic and stearic acid to palmitoleic 
and oleic acid, respectively, in the DNL pathway. The present 
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associations of PKD2L1 with palmitoleic and vaccenic acid, 
which is located near SCD. The results of the cis-eQTL anal-
ysis suggested that the most significant SNP, PKD2L1-
rs603424, was associated with the RNA level of SCD in the 
adipose tissue (P  3.94 × 106; supplemental Table S5). 
Therefore, PKD2L1-rs603424 may exert its effect on MUFA 
levels through regulating SCD transcription.
Genetic variants at FADS1/2 also showed significant 
associations with MUFA levels, including palmitoleic, 
vaccenic, oleic, and gondoic acid. FADS1/2 encode 5 and 
6 desaturases, predominantly involved in the PUFA bio-
synthesis pathway (43). Recent studies have indicated that 
6 desaturase can also catalyze palmitic and stearic acid to 
produce other unsaturated FAs (1, 44). Because palmitic 
and stearic acid serve as the substrates for MUFA endoge-
nous synthesis, it is possible that FADS1/2 influences spe-
cific MUFA levels through substrate regulation. The exact 
mechanisms underlying the associations between FADS1/2 
variants and MUFA levels merit further investigation.
GCKR encodes glucokinase regulator, a protein that in-
hibits glucokinase (GCK) activity in liver and pancreas 
(45). In the present study, substantial improvement of fine-
mapping resolution at this locus was observed, and the 
99% credible set calculated after trans-ethnic meta-analysis 
highlighted one missense variant (rs1260326, p.P446L). 
Functional studies have indicated that GCKR-rs1260326 
played a central role in regulation of GCK activity in the 
liver, which consequently influenced glycolytic flux and 
DNL (46, 47). Therefore, it is likely that rs1260326 is the 
variant driving the association of GCKR with palmitoleic 
acid through modifying the DNL pathway.
LPCAT3 encodes lysophosphatidylcholine acyltransfer-
ase 3, which is involved in lysophospholipid esterification 
(48). It was confirmed in the trans-ethnic meta-analysis us-
ing MANTRA, but not METAL. The inconsistent trans-eth-
nic meta-analysis results generated from MANTRA and 
METAL were mainly due to the different methods imple-
mented in these two software. MANTRA takes account of 
the expected similarity in allelic effects between the most 
closely related populations by using a Bayesian partition 
model and also allows for heterogeneity across ethnic 
groups (49). In contrast, METAL uses a fixed-effect model 
that assumes the allelic effect to be the same in all popula-
tions. Therefore, MANTRA confers significantly higher 
power than METAL (50).
In the ethnic-specific GWAS meta-analyses, the magni-
tude and directions of the identified associations were 
largely consistent across cohorts (supplemental Table S1 
and supplemental Fig. S3). Association analyses further 
stratified by the measurement methods (erythrocyte and 
plasma phospholipid FAs) did not materially changed 
the association results, and no additional erythrocyte- or 
plasma-specific loci were identified (supplemental Table 
S1). Association results after excluding the InCHIANTI co-
hort, which measured MUFA levels in total plasma, also 
remained largely unchanged. These results suggested that 
differences in MUFA measurements did not introduce 
noise in the association results and were similar to the find-
ings of previously published GWAS of FAs (18, 51).
In conclusion, this is the first study to provide evidence 
for the associations of FADS1/2, PKD2L1, and GCKR with 
vaccenic and/or gondoic acid levels in the populations of 
Chinese and European origin. Five previously reported loci 
(FADS1/2, PKD2L1, GCKR, HIF1AN, and LPCAT3) for pal-
mitoleic and/or oleic acid were also confirmed. Trans-ethnic 
fine-mapping highlighted a missense variant (rs1260326) 
at the GCKR locus. Our findings shed light on the genetic 
basis of MUFA biology and establish the foundation for fu-
ture genetic and functional investigations.
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